Abstract
Objectives
Computed tomography (CT) is the modality of choice to characterise pulmonary arteriovenous malformations (PAVMs) in patients with hereditary haemorrhagic telangiectasia (HHT). Our objective was to determine if CT findings were associated with frequency of brain abscess and ischaemic stroke.
Methods
This retrospective study included patients with HHT-related PAVMs. CT results, i.e. PAVM presentation (unique, multiple, disseminated or diffuse), the number of PAVMs and the largest feeding artery size, were correlated to prevalence of ischaemic stroke and brain abscess. All CTs were reviewed in consensus by two radiologists.
Results
Of 170 patients, 73 patients had unique (42.9 %), 49 multiple (28.8 %), 36 disseminated (21.2 %) and 12 diffuse (7.1 %) PAVMs. Fifteen patients presented with brain abscess; 26 patients presented with ischaemic stroke. The number of PAVMs was significantly correlated with brain abscess (11.5 vs. 6.2, respectively; p=0.025). The mean diameter of the largest feeding artery was significantly correlated with ischaemic stroke frequency (4.9 vs. 3.2 mm, respectively; p=0.0098).
Conclusions
The number of PAVMs correlated significantly with risk of brain abscess, and a larger feeding artery significantly with more ischaemic strokes. These findings can lead to a better recognition and management of the PAVMs at risk of cerebral complications.
Key Points
• Chest CT helps clinicians to facilitate appropriate PAVM management strategies.
• Pulmonary arteriovenous malformation CT findings are correlated with risk of cerebral complications.
• Risk of brain abscess is significantly correlated with number of PAVMs.
• Risk of ischaemic stroke is significantly correlated with large feeding artery PAVMs.
• Prevalence of observed of brain abscess and ischaemic stroke is 26 %.
Similar content being viewed by others
Abbreviations
- ALK1:
-
Activin receptor-like kinase-1
- AVM:
-
Arteriovenous malformation
- CIROCO:
-
Clinical Investigation and Research for the Rendu–Osler Cohort, national database for HHT in France
- CT:
-
Computed tomography
- ENG:
-
Endoglin
- FA:
-
Feeding artery
- HHT:
-
Hereditary haemorrhagic telangiectasia, Rendu–Osler disease
- MIP:
-
Mode maximum intensity projection on CT
- PAVM:
-
Pulmonary arteriovenous malformation
- SD:
-
Standard deviation
- TCE:
-
Transcatheter embolotherapy
References
Guttmacher AE, Marchuk DA, White RI (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med. 333:918–924
Cottin V, Chinet T, Lavolé A, Corre R, Marchand E, Reynaud-Gaubert M et al (2007) Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. Medicine (Baltimore). 86:1–17
Burke CM, Safai C, Nelson DP, Raffin TA (1986) Pulmonary arteriovenous malformations: a critical update. Am Rev Respir Dis. 134:334–339
Gossage JR, Kanj G (1998) Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med. 158:643–661
Lacombe P, Lacout A, Marcy P-Y, Binsse S, Sellier J, Bensalah M et al (2013) Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: An overview. Diagn Interv Imaging. 94:835–848
Cottin V, Dupuis-Girod S, Lesca G, Cordier J-F (2007) Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease). Respir Int Rev Thorac Dis. 74:361–378
Trerotola SO, Pyeritz RE (2010) PAVM embolization: an update. AJR Am J Roentgenol. 195:837–845
McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE et al (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 8:345–351
Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. 13:189–195
Iyer NK, Burke CA, Leach BH (2010) Parambil JG. SMAD4 mutation and the combined syndrome of juvenile polyposis syndrome and hereditary haemorrhagic telangiectasia. Thorax. 65:745–746
Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S et al (2004) A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet Lond Engl. 363:852–859
Dupuis-Girod S, Giraud S, Decullier E, Lesca G, Cottin V, Faure F et al (2007) Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated association. Clin Infect Dis Off Publ Infect Dis Soc Am. 44:841–845
Shovlin CL, Jackson JE, Bamford KB, Jenkins IH, Benjamin AR, Ramadan H et al (2008) Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax. 63:259–266
Faughnan ME, Lui YW, Wirth JA, Pugash RA, Redelmeier DA, Hyland RH et al (2000) Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. Chest. 117:31–38
Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD et al (2011) International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 48:73–87
Carette M-F, Nedelcu C, Tassart M, Grange J-D, Wislez M, Khalil A (2009) Imaging of hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol. 32:745–757
Maher CO, Piepgras DG, Brown RD, Friedman JA, Pollock BE (2001) Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke. 32:877–882
Lee DW, White RI, Egglin TK, Pollak JS, Fayad PB, Wirth JA et al (1997) Embolotherapy of large pulmonary arteriovenous malformations: long-term results. Ann Thorac Surg. 64:930–939 discussion 939-940
Letourneau-Guillon L, Faughnan ME, Soulez G, Giroux M-F, Oliva VL, Boucher L-M et al (2010) Embolization of pulmonary arteriovenous malformations with amplatzer vascular plugs: safety and midterm effectiveness. J Vasc Interv Radiol JVIR. 21:649–656
White RI, Lynch-Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L et al (1988) Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology. 169:663–669
White RI, Pollak JS, Wirth JA (1996) Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol JVIR. 7:787–804
Mager JJ, Overtoom TTC, Blauw H, Lammers JWJ, Westermann CJJ (2004) Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients. J Vasc Interv Radiol JVIR. 15:451–456
Pollak JS, Saluja S, Thabet A, Henderson KJ, Denbow N, White RI (2006) Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. J Vasc Interv Radiol JVIR. 17:35–44 quiz 45
Gupta S, Faughnan ME, Bayoumi AM (2009) Embolization for pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia: a decision analysis. Chest. 136:849–858
Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ et al (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 91:66–67
Remy J, Remy-Jardin M, Giraud F, Wattinne L (1994) Angioarchitecture of pulmonary arteriovenous malformations: clinical utility of three-dimensional helical CT. Radiology. 191:657–664
Gamondès D, Si-Mohamed S, Cottin V, Gonidec S, Boussel L, Douek P et al (2016) Vein Diameter on Unenhanced Multidetector CT Predicts Reperfusion of Pulmonary Arteriovenous Malformation after Embolotherapy. Eur Radiol. 26:2723–2729
Pierucci P, Murphy J, Henderson KJ, Chyun DA, White RI (2008) New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: twenty-seven-year experience. Chest. 133:653–661
Lacombe P, Lagrange C, Beauchet A, El Hajjam M, Chinet T, Pelage J-P (2009) Diffuse pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: long-term results of embolization according to the extent of lung involvement. Chest. 135:1031–1037
Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M, Pollak J, Henderson K et al (2000) Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology. 55:959–964
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Professor Didier Revel.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
E. Decullier kindly provided statistical advice for this manuscript.
Informed consent
Written informed consent was obtained from all subjects (patients) in this study.
Ethical approval
Institutional Review Board approval was obtained.
Methodology
• retrospective
• observational
• performed at one institution
Electronic supplementary material
ESM 1
(DOCX 102 kb)
Rights and permissions
About this article
Cite this article
Etievant, J., Si-Mohamed, S., Vinurel, N. et al. Pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia: Correlations between computed tomography findings and cerebral complications. Eur Radiol 28, 1338–1344 (2018). https://doi.org/10.1007/s00330-017-5047-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-017-5047-x